Eurand Pharmaceuticals Report issue

For profit Phase 1
Founded: Vandalia OH United States (2007)
Status: Acquired by Aptalis (2011) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2010
NCT01159119
First Marketed Drug
2009
lipase
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ZENPEP